Sinopep-Allsino Biopharmaceutical Co. Ltd. A Capital Reinvestment Ratio

Latest as of September 2025: 4.91x

Sinopep-Allsino Biopharmaceutical Co. Ltd. A capital reinvestment ratio. Sinopep-Allsino Biopharmaceutical Co. Ltd. A (688076) has a Capital Reinvestment Ratio of 4.91x as of September 2025, meaning it reinvests 5% of its operating cash flow (CN¥68.66 Million) in capital expenditures (CN¥337.06 Million). Check Sinopep-Allsino Biopharmaceutical Co. Lt total reinvestment intensity to assess the company's total reinvestment commitment from operating cash flow.

Capital Reinvestment Ratio

4.91x
Capex / Operating Cash Flow

Operating Cash Flow

CN¥68.66 Million
CNY

Capital Expenditures

CN¥337.06 Million
CNY

Data as of

Sep 2025
Most recent filing

Capital Reinvestment Ratio of Sinopep-Allsino Biopharmaceutical Co. Ltd. A (2013–2025)

Capital reinvestment ratio of Sinopep-Allsino Biopharmaceutical Co. Ltd. A from 2013 to 2025. This chart tracks Sinopep-Allsino Biopharmaceutical Co. Ltd. A's Capital Reinvestment Ratio across 11 annual periods. Also explore Sinopep-Allsino Biopharmaceutical Co. Lt (688076) equity growth momentum to track the company's year-over-year net asset growth rate.

Sinopep-Allsino Biopharmaceutical Co. Ltd. A Capital Reinvestment Ratio by Year (2013–2025)

Sinopep-Allsino Biopharmaceutical Co. Ltd. A capital reinvestment ratio by year from 2013 to 2025. For the full cash flow conversion analysis, see 688076 cash flow conversion.

Year Reinvestment Ratio Operating CF (CNY) Capital Expenditures YoY Change
2025 2.01x CN¥681.24 Million CN¥1.37 Billion ▼ -26.3%
2024 2.72x CN¥400.12 Million CN¥1.09 Billion ▲ +44.4%
2023 1.89x CN¥350.21 Million CN¥660.64 Million ▼ -87.4%
2022 14.97x CN¥29.29 Million CN¥438.36 Million ▲ +1059.1%
2021 1.29x CN¥180.75 Million CN¥233.36 Million ▲ +64.0%
2020 0.79x CN¥141.38 Million CN¥111.28 Million ▼ -86.9%
2019 5.99x CN¥46.14 Million CN¥276.39 Million ▲ +191.4%
2018 2.06x CN¥96.06 Million CN¥197.48 Million ▼ -68.9%
2017 6.60x CN¥11.11 Million CN¥73.34 Million ▲ +4544.9%
2014 0.14x CN¥68.18 Million CN¥9.69 Million ▼ -74.8%
2013 0.56x CN¥43.67 Million CN¥24.63 Million —
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow